Igc Pharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Igc Pharma Inc inventory turnover ratio, the Igc Pharma Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 1.02 in the third quarter 2026, yet the ratio remained below the average, as IGC's market remain challenging.Average inventory processing period, for the Igc Pharma Inc in Sep 30 2026 quarter, has decreased to 358 days, compare to 406 days, in the Jun 30 2026 quarter.

Within Healthcare sector 324 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1581 in the second quarter 2026, to 1862.

IGC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Igc Pharma Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IGC Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Inventory Growth	-2.28 %	-52.56 %	-53.09 %	-5.09 %	-56.42 %
Y / Y Cost of Sales Growth	53.45 %	23.3 %	71.24 %	-57.01 %	59.63 %
Inventory Turnover Ratio (TTM)	1.02	0.9	0.7	0.5	0.6
IGC's Total Ranking	# 1862	# 1581	# 1634	#	#
Average inventory processing period	357	404	519	725	611
Seq. Inventory Growth	0.47 %	0.31 %	-53.09 %	106.69 %	-51.22 %
Seq. Cost of Sales Growth	23.04 %	-17.18 %	184.78 %	-47.13 %	-1.14 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 98
Healthcare Sector	# 325
Overall Market	# 1862

Inventory Turnover Ratio Statistics
High	Average	Low
15.88	4.85	0.04
(Jun 30 2013)		(Dec 31 2021)

IGC Company Profile >> Back to IGC Efficiency Comparisons >> Compare IGC Inventory Turnover Ratio to its Competitors

Financial Statements
Igc Pharma Inc 's Inventories	$ 1 Millions	Visit IGC's Balance sheet
Igc Pharma Inc 's Cost of Revenues TTM	$ 1 Millions	Visit IGC's Income Statement
What are IGC's Sales?		Visit IGC's Sales by Segment

Other Inventory Turnover Ratios
Igc Pharma Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IGC's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IGC's Competitors
Inventory Turnover Ratio for IGC's Suppliers
Inventory Turnover Ratio for IGC's Customers

You may also want to know
IGC's Sales Growth Rates	IGC's Pe Price to earnings ratio	IGC's Receivables Turnover Ratio	IGC's Stock Quote
IGC's Net Income Growth Rates	IGC's Ps Price to Sales ratio	IGC's Sales per Employee	IGC's Asset Turnover Ratio
IGC's Net Margin	IGC's Pb Price to Book ratio	IGC's Financial Strength Ratios	IGC's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Baxter International Inc	3.57	$ 8,117.000 Millions	$ 2,277 Millions
Bausch Health Companies Inc	3.54	$ 4,518.000 Millions	$ 1,276 Millions
Coherus Oncology inc	3.50	$ 16.193 Millions	$ 5 Millions
Exelixis Inc	3.49	$ 93.324 Millions	$ 27 Millions
Abbvie Inc	3.40	$ 17,346.000 Millions	$ 5,108 Millions
Gilead Sciences Inc	3.30	$ 6,219.000 Millions	$ 1,884 Millions
Iovance Biotherapeutics inc	3.21	$ 177.232 Millions	$ 55 Millions
Teva Pharmaceutical Industries Limited	3.16	$ 8,011.000 Millions	$ 2,537 Millions
Msa Safety Inc	3.00	$ 1,063.235 Millions	$ 354 Millions
Mimedx Group Inc	2.98	$ 70.562 Millions	$ 24 Millions
Abbott Laboratories	2.95	$ 20,765.000 Millions	$ 7,032 Millions
Revvity Inc	2.93	$ 1,122.448 Millions	$ 384 Millions
Ligand Pharmaceuticals Incorporated	2.93	$ 34.495 Millions	$ 12 Millions
Zai Lab Limited	2.91	$ 200.083 Millions	$ 69 Millions
Amneal Pharmaceuticals Inc	2.90	$ 1,910.255 Millions	$ 658 Millions
Neogen Corporation	2.89	$ 464.774 Millions	$ 161 Millions
Ani Pharmaceuticals Inc	2.87	$ 405.540 Millions	$ 142 Millions
Zevra Therapeutics Inc	2.82	$ 6.736 Millions	$ 2 Millions
Biomerica Inc	2.65	$ 4.297 Millions	$ 2 Millions
Dexcom Inc	2.65	$ 1,867.500 Millions	$ 705 Millions
Dentsply Sirona Inc	2.65	$ 1,769.000 Millions	$ 668 Millions
Avita Medical Inc	2.58	$ 14.936 Millions	$ 6 Millions
Angiodynamics Inc	2.50	$ 142.709 Millions	$ 57 Millions
Abeona Therapeutics Inc	2.46	$ 13.630 Millions	$ 6 Millions
Pro dex Inc	2.45	$ 53.753 Millions	$ 22 Millions
Illumina Inc	2.36	$ 1,458.000 Millions	$ 618 Millions
Tela Bio Inc	2.35	$ 26.999 Millions	$ 11 Millions
Mirum Pharmaceuticals Inc	2.35	$ 59.684 Millions	$ 25 Millions
Aquestive Therapeutics Inc	2.34	$ 16.928 Millions	$ 7 Millions
Lifevantage Corp	2.33	$ 39.482 Millions	$ 17 Millions

Date modified: 2026-11-07T13:18:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.